Selank Results Timeline
What the standard Selank research protocol looks like phase by phase, over a typical 2–4 weeks (intensive) or 8–12 weeks cycle. This is the escalation schedule from our full dosing protocol, presented as a timeline rather than a table.
Quick Facts
FREQUENCYOnce or twice daily
CYCLE LENGTH2–4 weeks (intensive) or 8–12 weeks
DOSE RANGE250–500 mcg per dose
ROUTESubcutaneous injection
Phase-by-Phase Timeline
Loading / Titration
Weeks 1–2
Target dose: 250 mcg
Maintenance
Weeks 3+
Target dose: 500 mcg
Reported in Research
- ✓Intensive: 2–4 weeks.
- ✓Extended: 8–12 weeks.
This timeline reflects the structure of the standard Selank research protocol documented on this site — it is not a guarantee of individual outcomes, and timelines vary between research subjects. All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.